• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Principal Contrarian Value Index ETF (NY:PVAL)

48.61 +0.23 (+0.48%)
Official Closing Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,296,601
Open 48.25
Bid (Size) 47.72 (5,100)
Ask (Size) 48.69 (5,100)
Prev. Close 48.38
Today's Range 48.11 - 48.61
52wk Range 32.83 - 49.13
Shares Outstanding 897,290
Dividend Yield 0.92%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Novo Nordisk Reportedly Eyes Launching Wegovy In Vials To Compete With Rival Eli Lilly ↗
February 11, 2026
Bloomberg reported on Wednesday, citing Novo CEO Mike Doustdar, that the vials are slated to be introduced in the U.S. this year. 
Via Stocktwits
Topics Intellectual Property
News headline image
FDA Says Novo's Wegovy Pill TV Advertisement Is Misleading: NVO Stock Pares Gains ↗
February 09, 2026
According to an FDA letter dated February 5, the agency stated that the advertisement “misbrands” Wegovy. 
Via Stocktwits
Topics Lawsuit

Performance

YTD
+5.7%
+5.7%
1 Month
+5.3%
+5.3%
3 Month
+13.5%
+13.5%
6 Month
+18.0%
+18.0%
1 Year
+22.8%
+22.8%

More News

Read More
News headline image
Novo Nordisk Sues Hims & Hers Over Compounded Wegovy, Calls For Permanent Sales Ban: HIMS Stock Tanks ↗
February 09, 2026
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
Sanofi, VNVC Launch Vaccine Manufacturing Facility In Vietnam, Says Report: Retail’s Positive ↗
May 27, 2025
Via Stocktwits
News headline image
Putnam Investments Launches Firm’s First Active ETFs
May 26, 2021
From Putnam Investments
Via Business Wire

Frequently Asked Questions

Is Principal Contrarian Value Index ETF publicly traded?
Yes, Principal Contrarian Value Index ETF is publicly traded.
What exchange does Principal Contrarian Value Index ETF trade on?
Principal Contrarian Value Index ETF trades on the New York Stock Exchange
What is the ticker symbol for Principal Contrarian Value Index ETF?
The ticker symbol for Principal Contrarian Value Index ETF is PVAL on the New York Stock Exchange
What is the current price of Principal Contrarian Value Index ETF?
The current price of Principal Contrarian Value Index ETF is 48.61
When was Principal Contrarian Value Index ETF last traded?
The last trade of Principal Contrarian Value Index ETF was at 02/20/26 04:00 PM ET
What is the market capitalization of Principal Contrarian Value Index ETF?
The market capitalization of Principal Contrarian Value Index ETF is 43.62M
How many shares of Principal Contrarian Value Index ETF are outstanding?
Principal Contrarian Value Index ETF has 44M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap